| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 115 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 114 |
| 2 | TACROLIMUS OINTMENT 0.1% | 114 |
| 3 | PREDNISONE | 100 |
| 4 | MYCOPHENOLATE MOFETIL | 83 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 83 |
| 6 | MYCOPHENILIC ACID | 36 |
| 7 | MYCOPHENOLIC ACID | 36 |
| 8 | CYCLOSPORINE | 22 |
| 9 | VALGANCICLOVIR | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 5 | 0.0360 |
| 1 | TECOVIRIMAT MONOHYDRATE | 3 | 0.0288 |
| 2 | ABACAVIR AND LAMIVUDINE | 2 | 0.0100 |
| 3 | CABOTEGRAVIR SODIUM | 10 | 0.0062 |
| 4 | CIDOFOVIR ANHYDROUS | 9 | 0.0062 |
| 5 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 15 | 0.0042 |
| 6 | RALTEGRAVIR | 14 | 0.0027 |
| 7 | ETRAVIRINE | 10 | 0.0023 |
| 8 | FINGOLIMOD HYDROCHLORIDE | 10 | 0.0020 |
| 9 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 3 | 0.0288 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 36 | 0.0017 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 21 | 0.0009 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 10 | 0.0007 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 32 | 0.0007 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 46 | 0.0004 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0004 |
| 8 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 9 | Antimalarial [EPC] | 2 | 0.0002 |